Ying Zhang
Impact in
- Infectious Diseases top 0.05%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 126
- Antimicrobial Resistance in Staphylococcus 22
-
- Antibiotic Resistance in Bacteria 31
- Co-authors
- Wanliang ShiAngelo ScorpioDouglas B. YoungWenhong ZhangBéate HeymStewart T. ColeB.W. AllenZhonghe Sun
- Journals
- Antimicrobial Agents and Chemotherapy (19 papers)Frontiers in Microbiology (17 papers)Antibiotics (12 papers)PLoS ONE (11 papers)Respirology (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ying Zhang
280 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Infectious Diseases 6.8k
- Molecular Medicine 1.4k
- Epidemiology 5.4k
- Parasitology 601
- Endocrinology 384
Countries citing papers authored by Ying Zhang
This map shows the geographic impact of Ying Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Zhang more than expected).
Fields of papers citing papers by Ying Zhang
This network shows the impact of papers produced by Ying Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Zhang. The network helps show where Ying Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 16 | |
| 13 | 2018 | 18 | |
| 14 | 2018 | 28 | |
| 15 | 2018 | 29 | |
| 16 | 2017 | 27 | |
| 17 | 2015 | 29 | |
| 18 | 2013 | 225 | |
| 19 | Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis Hit paper breakdown → | 2011 | 392 |
| 20 | 2009 | 13 |
About Ying Zhang
Ying Zhang is a scholar working on Infectious Diseases, Molecular Medicine, Parasitology, Epidemiology and Endocrinology, having authored 293 papers that have together received 12.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (126 papers), Mycobacterium research and diagnosis (95 papers), Antibiotic Resistance in Bacteria (31 papers), Cancer therapeutics and mechanisms (26 papers), Antimicrobial Resistance in Staphylococcus (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (20 papers), Vector-borne infectious diseases (19 papers) and Bacterial Genetics and Biotechnology (18 papers). The work is most often cited by research in Infectious Diseases (6.8k citations), Molecular Medicine (1.4k citations), Epidemiology (5.4k citations), Parasitology (601 citations) and Endocrinology (384 citations). Ying Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wanliang Shi, Angelo Scorpio, Douglas B. Young, Wenhong Zhang, Béate Heym, Stewart T. Cole, B.W. Allen, Zhonghe Sun, Jie Feng and Peng Cui. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, Antibiotics, PLoS ONE and Respirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.